1) Prognosis in Chronic Lymphocytic Leukemia. A Retrospective Multicentric Study From the GIMEMA Group
F. Mandelli, G. De Rossi, P. Mancini, A. Alberti, A. Cajozzo, F. Grignani, P. Leoni, V. Liso, M. Martelli, A. Neri, L. Resegotti, G. Torlontano
J Clin Oncology 5, 398, 1987
2) Chronic Lymphocytic Leukemia (CLL): prognostic factors in Adults and Younger Adults Patients. A Cooperative (GIMEMA) Retrospective Study.
G. De Rossi, F. Mandelli, A. Covelli at al.
Chronic Lymphocytic Leukemia: recent progress and future direction.
UCLA Symposia 59, Ed. R.P. Gale and K. R. Rai, 289-305, 1987
3) Chronic Lymphocytic Leukemia (CLL) in younger adults. A retrospective study in 133 cases
G. De Rossi, F. Mandelli, A. Covelli, M. Luciani, M. Martelli, L. Resegotti, A. Alberti, A. Cajozzo, L. Deriu, R. De Biase, G. Broccia, A. Abbadessa, F. Caronia, P. Leone
Hematol Oncol 7, 127, 1989
4) Clonally expanded CD3+, CD4-, CD8- Cells bearing the / or the / T-cell receptor in
patients with the Lymphoproliferative Disease of Granular Lymphocytes.
F. Pandolfi, R. Foà, G. De Rossi, et al.
Clinical Immunol Immunopath 60, 371, 1991
5) Immunophenotype of Acute lymphoblastic Leukemia Cells: The experience of the Italian Cooperative Group (GIMEMA)
G. De Rossi, C. Grossi, R. Foà et al.
Leukemia and Lymphoma 9, 221, 1993
6) Prognostic Features and Therapeutical approaches in B-cell Chronic Lymphocytic Leukemia: An Update.
S. Molica and G. De Rossi
Haematologica 8, 176, 1995
7) Increased serum levels of soluble CD44 standard, but not variant isoforms V5 and V6, in B-cell Chronic Lymphocytic Leukemia
G. De Rossi, P. Marroni, M. Panuzzi et al.
Leukemia, 11: 134, 1997
8) Changes in adhesion molecule expression on lymphoblasts during Acute Lymphoblastic
Leukemia treatment
G. De Rossi, C. Grossi
J. Pediatrics, 134: 525, 1999
9) Mechanism of Osteoclast Dysfunction in human Osteopetrosis. Abnormal
Osteoclastogenesis and lack of Osteoclast-specific Adhesion Structures.
A. Teti, S. Migliaccio, A. Taranta, S. Bernardini, G. De Rossi, et al.
J Bone and Min Res. 14, 2107, 1999
10) A prospective study of residual disease monitoring of the ALL1/AF4 transcript in patients with t(4;11) acute lymphoblastic leukemia.
G. Cimino, L. Elia, MC Rapanotti, T. Sprovieri, M. Mancini, A. Cuneo, C. Mecucci, M. Carotenuto, E. Morra, V. Liso, L. Annino, G. Saglio, G. De Rossi, R. Foà, F. Mandelli.
Blood 95, 96, 2000
11) Allogeneic Bone Marrow Transplantation for Infantile Globoid-Cell
Leukodistrophy “Krabbe Disease”
M. Caniglia, I. Rana, RM. Pinto, R. Caruso, C. Dionisi Vici, A. Angioni,
G. Sabetta, G. De Rossi
Pediatric Transplantation 6; 427; 2002
12) Treatment of acute childhood idiopathic thrombocytopenic purpura with methylprednisolone pulses at high doses.
C. Baronci, R. Caruso, I. Rana, M.B. Pinazzi, V. Coletti, R.M. Pinto, A. Petrone, G. De Rossi
Haematologica, 6 (4): 475-478, 2003
13) High Clonal Evolution Rate in Relapsing Infant ALL patients
G. Cazzaniga, L. Corral, M. Luciani, S. Songia, P. De Lorenzo, M. Spinelli, L. Lo Nigro, G. Basso, G. De Rossi, A. Biondi
ASH Forty-six annual meeting
S. Diego, California, 4-7 dicembre 2004
Blood 2004, 104, n 11; p. 51a
14) CD1d expression on B-precursor acute lymphoblastic leukemia subsets with poor prognosis.
F. Fais, C. Tenca, G. Cimino, V. Coletti, S. Zanardi, D. Bagnara, D. Saverino, D. Zarcone, G. De Rossi, et al.
Leukemia: 19: 551-6; 2005
15) Role of treatment intensification in infants, with acute lymphoblastic leukemia: results of two consecutive AIEOP studies.
A. Biondi, C. Rizzari., MG Valsecchi, P. De Lorenzo, M. Aricò, G. Basso, F. Locatelli, L. Lo Nigro, G. De Rossi, G. Masera.
Haematologica 9,102-105, 2006
16) A treatment protocol for infants younger than 1 year with acute lymphoblastic
leukemia (Interfant-99): an observational study and a multicentre randomized
trial
R. Pieters, M. Schrappe, P. De Lorenzo, I. Hann, G. De Rossi, et al.
Lancet i, 240, 2007
17) Therapy with high-dose dexamethasone (HD-DXM) in previously untreated
patients affected by idiopathic thrombocytopenic purpura: a GIMEMA experience
M.G. Mazzucconi, P. Fazi, S. Bernasconi, G. De Rossi, et al.
Blood 109, 1401, 2007
18) Evidence-based reccomandations on the treatment of von Willebrand disease in
Italy
Mannucci PM, Franchini M, Castaman G, Federici AB, and De Rossi G and al
0n behalf AICE
Trasfusion 7, 117, 2009
18) Comparison of the rates of joint arthroplasty in patients with severe factor VIII
and IX deficiency : an index of different clinical severity of the 2 coagulation disorders
Tagariello G, Iorio A, Santagostino E, Morfini M, Bisso R, Innocenti M, Mancuso ME, Mazzucconi MG, Pasta GL, Radossi P, Rodorigo G, Santoro C, Sartori R, Scaraggi A, Solimeno LP , Mannucci PM , and De Rossi G et al on behalf AICE collaborators
Blood 114, 779 ,2009
19) Pharmacokinetics of Daunorubicin and Daunorubicinol in Infants
with leukemia treated in Interfant 99 Protocol
G.Hempel ,M.V.Relling, G.De Rossi , et al
Pediatr Blood Cancer 54, 355, 2010
20) Improved outcome with hematopoietic stem cell transplantation in
a poor prognostic subgroup of infants with mixed-lineage-leukemia
(MLL)-rearranged acute lymphoblastic leukemia: results from the
Interfant 99 Study
Mann G., Attarbaschi A., Schrappe M.,De Lorenzo P., Peters C.,
Hann I., De Rossi G., et al
Blood 116, 2644, 2010
21) Molecular characterization of paediatric idiopathic hypereosinophilia
Rapanotti MC, Caruso R,Ammatuna E, Zaza S, Trotta L, Divona M, Cicconi L, Funaro D, Federici G. Amadori S, De Rossi G, Lo Coco F.
Br. J. Haemat. 151, 440-6, 2010
22) Clofarabine, cyclophosphamide, and Etoposide for the treatment of
Relapsed or Resistant Acute Leukemia in pediatric patients.
Miano M, Pistori A, Putti MC, Dufour C, Messina C, Barisone E,
Zino O, Parasole R, Luciani M, Lo Nigro L, De Rossi G, et al.
Leuk.Lymphoma 53, 1693-8, 2012.
23) A soluble form of CTLA-4 is present in paediatrics patients with
Acute Lymhoblastic Leukemia and correlates with CD1+ expres-
Sion.
Simone R., Tenca C., Fais F., Luciani M., De Rossi G., Pesce GP.,
Bagnasco M., Saverino D.
PloS one 7 (9) :e44654, 2012